Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Viruses|January 20, 2019
Middle East Respiratory Syndrome Vaccine Candidates: Cautious OptimismCraig Schindewolf, Vineet D Menachery
Virus Research|August 27, 2023
Coronavirus 2'-O-methyltransferase: A promising therapeutic targetCraig Schindewolf, Vineet D Menachery
Journal of Virology|September 17, 2020
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoVKumari G Lokugamage, Adam Hage, Maren de Vries, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoVKumari G Lokugamage, Adam Hage, Maren de Vries, et al.
NPJ Vaccines|March 18, 2022
Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and developmentMegan A Files, Clairissa A Hansen, Vanessa C Herrera, et al.
Biorxiv : the Preprint Server for Biology|August 31, 2021
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variantYang Liu, Jianying Liu, Bryan A Johnson, et al.
Cell Reports|May 13, 2022
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variantYang Liu, Jianying Liu, Bryan A Johnson, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
The N501Y spike substitution enhances SARS-CoV-2 transmissionYang Liu, Jianying Liu, Kenneth S Plante, et al.
Nature|November 24, 2021
The N501Y spike substitution enhances SARS-CoV-2 infection and transmissionYang Liu, Jianying Liu, Kenneth S Plante, et al.
Journal of Ovarian Research|December 6, 2014
Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypesAyala Tamir, Ushma Jag, Sreeja Sarojini, et al.
Pageof 3